Your donation will make a difference:
Cystic Fibrosis Trust
  • Home
  • /
  • Home
  • /
  • News
  • /
  • New Lung Clearance Index package to boost access to trials

New Lung Clearance Index package to boost access to trials

New training and equipment provided by the Trust’s Clinical Trials Accelerator Platform will ensure a wider range of clinical trials are accessible to the UK cystic fibrosis (CF) community.

black and white doodle of lungs As the CF population becomes increasingly healthier with the arrival of highly effective modulator therapy, more sensitive outcome measures will be needed and used more frequently in CF clinical trials looking to improve lung function.

Lung Clearance Index (LCI) is a sensitive measure of lung function and is becoming a more frequent outcome measure in CF clinical trials in both adults and children; however, LCI machines are considerably costly and require specialist training to use.

To meet this growing need, the Trust’s Trials Accelerator will use part of the recent £2.1 million funding from the Cystic Fibrosis Foundation (CFF) to provide Trial Accelerator centres across the UK with access to the necessary training and equipment needed to run clinical trials involving LCI.

Under the ‘LCI Training Package’, the Trust will purchase six LCI machines and train staff from participating CF centres in how to use the equipment and report the results required for clinical trials. Once staff are certified, the machines will be available for loan for clinical trial use at Trial Accelerator centres.

The generous funding from the CFF will help to further develop the most effective treatments for people affected by CF while staying up to date with the latest clinical trial advances.

Professor Jane Davies, honorary consultant in paediatric respiratory medicine at Royal Brompton & Harefield NHS Foundation Trust, said: "As LCI has become more commonly used as a trial read-out, it’s been frustrating for enthusiastic sites not yet LCI-ready to be excluded. The European CF Society established a Core facility run out of the Brompton centre to provide training and certification in nitrogen multibreath washout, which has led to great improvements in standardisation across the European CTN sites. We are delighted to now have the resources through CTAP to provide this support to other centres across the UK." Jane is also Chair of the Trials Accelerator Governance Board. 

The LCI Training Package will commence in spring 2020 and take approximately one year to train staff from participating centres.

Stay in touch to hear about clinical trials and ways you can help us pave the way for transformative new treatments by signing up to our quarterly clinical trials newsletter.  

Related content

  • Triple timeline announced by NICE

    Yesterday, NICE announced its planned timelines for assessing the triple combination therapy, with 16 December 2020 the date they expect to publish...

  • A storm is coming!

    The Cystic Fibrosis Trust was delighted to hear that the CF STORM trial has received £1.5m funding from the Government’s National Institute of...

  • UK CF Medical Association's statement on coronavirus

    If you have questions that are not answered in the below please contact our Helpline on While we endeavour to...

  • My summer of CF research

    What sparked your interest in cystic fibrosis? While I was doing my A Levels, I worked as a health care support worker part time. It was my first...